MENOPAUSE & MIDLIFE / Information for better care conversationsNeed urgent help?

Blood tests and menopause assessment

Questions to ask before buying a hormone test or broad diagnostic package.

A menopause consultation does not always need a hormone blood test. For many people aged 45 or over with a typical history, assessment is based on symptoms, menstrual changes and relevant medical information. Testing is more useful when it answers a specific question, such as investigating an earlier-than-expected menopause or another possible cause of symptoms. [1] [2]

The important question is not whether a clinic offers a large panel. It is whether each result could change an appropriate decision. This guide explains what tests can and cannot tell you and how to avoid both unnecessary testing and dismissal of symptoms.

Why a clinical history often matters more

Perimenopause is a transition, not a fixed hormone state. Hormone levels can vary during this period, so a result taken on one day may not describe the pattern over several months. A normal result does not necessarily rule out perimenopause, and an abnormal result does not automatically explain every symptom. [2]

A clinician considers your age, period pattern, symptoms, medicines and surgical history together. They may also ask what has changed from your usual baseline and how the changes affect daily life. These details help determine whether the picture is typical or needs further investigation.

Preparing that history is often more useful than collecting unrelated test results before an appointment. Note approximate dates, contraception, major health changes and the two or three concerns that most need attention. You do not need a perfectly completed diary to deserve an assessment.

What is FSH, and why is it sometimes measured?

Follicle-stimulating hormone, or FSH, is involved in the signalling between the brain and ovaries. It can be relevant when ovarian function is changing, but interpretation depends on the context. Menopause guidelines reserve its use for selected situations rather than treating it as a universal screening test for anyone with fatigue or poor sleep. [1]

Ask why the test is being requested and whether medicines or the timing of the sample affect interpretation. A result should come with an explanation of what it supports, what remains uncertain and whether another assessment is needed. A laboratory flag alone is not a diagnosis.

Do not use a home FSH test to decide that contraception can stop. Pregnancy risk and decisions about contraception require a separate discussion, especially when hormonal medicines alter bleeding patterns. Our contraception guide explains that distinction in more detail.

Testing before age 45 is a different discussion

Symptoms suggesting early menopause, and especially possible premature ovarian insufficiency before age 40, deserve assessment rather than automatic reassurance that you are too young. Blood tests may have an important role in that work-up. The clinician may also investigate other causes of absent or irregular periods. [3] [4]

Diagnostic criteria and recommendations about repeat testing differ between guidelines and circumstances. Ask which criteria your clinician is using and whether uncertainty requires another sample or specialist review. Do not interpret a single result from a commercial panel as a complete diagnosis of ovarian insufficiency. [5]

If a diagnosis is confirmed, the conversation should extend beyond the laboratory number. It may include symptoms, fertility, contraception, bone health, emotional support and appropriate hormone treatment. The early menopause guide explains why an ongoing care plan matters more than simply receiving a label.

Medicines can change the picture

Hormonal contraception, HRT and treatments that suppress ovarian function can affect bleeding patterns or hormone measurements. A lack of periods while using a medicine does not necessarily show that natural menopause has occurred. Tell the clinician exactly what you take and when it was started or changed. [1]

Bring the actual packaging or a current prescription list when product names are unclear. Include injections, intrauterine systems, creams, compounded preparations and supplements. A description such as a hormone gel may not provide enough information to interpret a result or plan another test.

Do not stop contraception, cancer treatment or prescribed hormones simply to produce a supposedly clearer test. Ask whether testing is needed at all and, if so, how it can be arranged safely. The clinician should explain both the purpose and any implications of changing a medicine.

Investigating other causes is not dismissing menopause

Fatigue, anxiety, palpitations, memory difficulties and irregular periods can have more than one explanation. Depending on the history, a clinician may consider tests for anaemia, thyroid problems, glucose abnormalities or other conditions. The appropriate selection is individual; not everyone needs every test. [6] [7]

It is reasonable to ask how another diagnosis could overlap with menopause rather than replace it. Someone may need treatment for iron deficiency and help with hot flushes, for example. Identifying one problem should not prevent the remaining symptoms from being discussed.

Equally, a normal set of routine tests should not end the conversation when symptoms continue. Ask what the next step will be: reviewing sleep, examining a specific symptom, considering mental health, or arranging follow-up. Good assessment includes a plan for uncertainty, not only a list of normal results.

What about oestrogen levels and HRT monitoring?

Routine HRT care is not simply a process of moving an oestrogen result into a universal ideal range. Clinical response, side effects, the treatment formulation and personal risks are central to review. Testing may be appropriate in selected circumstances, but the prescriber should explain the decision it is intended to inform. [2] [8]

Ask what would happen if the result were high, low or unchanged. If every possible result leads to the same recommendation, the value of the test deserves discussion. Avoid increasing a medicine yourself because an online forum recommends a target number.

A useful review records whether the symptoms being treated improved, whether bleeding or other unwanted effects occurred, and whether the regimen remains suitable. It can also identify an application problem or another cause of symptoms without assuming that the hormone dose must always increase.

Testosterone testing has a specific monitoring role

Testosterone levels do not diagnose distressing low sexual desire on their own. When treatment is considered for an appropriate indication, measurement can help establish a baseline and monitor against excessive exposure. The history and the person’s experience remain essential to assessing benefit. [9]

A clinician should explain the relevant laboratory method, timing and follow-up rather than presenting a high number as a desirable goal. Different units and reference ranges can make results from separate laboratories difficult to compare without professional interpretation.

Our testosterone guide explains the difference between assessing sexual wellbeing and selling a general hormone-optimisation package. A treatment should have a clear purpose, realistic expectations and a plan for stopping or reconsidering it if it is not helpful.

Home tests and large commercial panels

A home sample can be convenient for a properly selected test, but convenience does not establish clinical usefulness. Check who requests the test, which laboratory processes it, how results are interpreted and what happens when an urgent or unclear finding appears. A PDF report without a responsible clinician may leave more uncertainty than it resolves.

Be cautious about packages that promise to reveal the exact cause of every menopause symptom or calculate when your final period will occur. A single biomarker should not be used as a precise individual countdown without evidence supporting that use. Tests developed for fertility questions may not answer the question you are asking.

Repeated saliva or urine panels marketed as a way to balance all hormones also deserve scrutiny. The Endocrine Society identifies important evidence limitations in saliva-guided custom hormone prescribing. Ask for a clear clinical rationale rather than accepting the size or visual sophistication of the report as proof of value. [10]

Understanding results without overinterpreting them

A reference interval describes how a laboratory interprets a measurement within a defined context; it is not a guarantee of health or a personalised treatment target. Results need to be considered alongside symptoms, examination, medicines and the reason for testing. Ask the clinician to explain the result in that context.

Keep a record of the date, laboratory, units and relevant treatment at the time. This is more useful than saving an isolated screenshot with a red flag. When comparing results, ask whether any apparent change could reflect timing or a different testing method rather than a meaningful clinical shift.

Request a written next step. That might be no action, a repeat test, a medication review or referral. Clarify who is responsible for contacting you and how to obtain advice if you do not hear back. Do not assume that silence from a clinic means every result has been reviewed.

Getting value from an assessment

Before purchasing a test, ask four practical questions: what is the clinical question, why is this test suitable, what would change after the result, and who will explain it? Those questions are useful in both public and private care. They are not a rejection of testing; they are a way to make testing purposeful.

Bring previous relevant results so that unnecessary repetition can be avoided. However, do not let an old normal result prevent reassessment when symptoms have changed. A good plan responds to the current situation rather than relying indefinitely on a panel from a different stage of life.

Use our appointment planner to organise symptoms and questions. The aim is neither the fewest tests nor the largest panel. It is an assessment that takes your experience seriously, investigates what needs investigating and leads to care you understand.

Sources you can inspect

  1. NICE: Menopause: identification and management (NG23), recommendations
  2. Australasian Menopause Society: Diagnosing menopause
  3. NHS: Early or premature menopause
  4. NICHD, NIH: Primary ovarian insufficiency
  5. American Society for Reproductive Medicine: Evidence-based guideline: premature ovarian insufficiency (2024)
  6. NHS: Tiredness and fatigue
  7. NHS: Heart palpitations
  8. NHS: When to take hormone replacement therapy (HRT)
  9. Journal of Clinical Endocrinology & Metabolism: Global consensus position statement on testosterone therapy for women (2019)
  10. Endocrine Society: Compounded bioidentical hormone therapy

Sources consulted 21 September 2026. This date records source consultation, not individual medical review. Provider descriptions are self-published and require direct verification.

Educational information, not personal medical advice. This draft has not received individual clinical review. No diagnostic score, prescribing or clinical monitoring is provided. Read the editorial standards.